Parathyroid hormone-related protein is reduced in severe chronic heart failure

Peptides

Volumn 27, Issue 7, 2006, Pages 1894-1897

  Giannakoulas, George ^a   Karvounis, Haralambos ^a   Koliakos, George ^a   Damvopoulou, Thalia ^a   Karamitsos, Theodoros ^a   Papadopoulos, Christodoulos ^a   Dalamanga, Emmanouela ^a   Hatzitolios, Apostolos ^a   Parcharidis, George ^a   Louridas, George ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; FUROSEMIDE; INOTROPIC AGENT; LEVOSIMENDAN; PARATHYROID HORMONE RELATED PROTEIN; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOWN REGULATION; FEMALE; HEART FAILURE; HEART FUNCTION; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; MALE; PARACRINE SIGNALING; PRIORITY JOURNAL;

AGED; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE-RELATED PROTEIN;

EID: 33744988976     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.01.014     Document Type: Article

References (14)

1. Burton D.W., Brandt D.W., and Deftos L.J. Parathyroid hormone-related protein in the cardiovascular system. Endocrinology 135 (1994) 253-261
2. DiPette D.J., Christenson W., Nickols M.A., and Nickols G.A. Cardiovascular responsiveness to parathyroid hormone (PTH) and PTH-related protein in genetic hypertension. Endocrinology 130 (1992) 2045-2051
3. Dzau V.J. Autocrine and paracrine mechanisms in the pathophysiology of heart failure. Am J Cardiol 70 (1992) 4C-11C
4. Eto M., Akishita M., Ishikawa M., Kozaki K., Yoshizumi M., Hashimoto M., et al. Cytokine-induced expression of parathyroid hormone-related peptide in cultured human vascular endothelial cells. Biochem Biophys Res Commun 249 (1998) 339-343
5. Halapas A., Tenta R., Pantos C., Cokkinos D.V., and Koutsilieris M. Parathyroid hormone-related peptide and cardiovascular system. In Vivo 17 (2003) 25-432
6. Kremer R., Shustik C., Tabak T., Papavasiliou V., and Goltzman D. Parathyroid-hormone-related peptide in hematologic malignancies. Am J Med 100 (1996) 406-411
7. Ogino K., Burkhoff D., and Bilezikian J.P. The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology 136 (1995) 3024-3030
8. Ogino K., Ogura K., Kinugasa Y., Furuse Y., Uchida K., Shimoyama M., et al. Parathyroid hormone-related protein is produced in the myocardium and increased in patients with congestive heart failure. J Clin Endocrinol Metab 87 (2002) 4722-4727
9. Qian J., Lorenz J.N., Maeda S., Sutliff R.L., Weber C., Nakayama T., et al. Reduced blood pressure and increased sensitivity of the vasculature to parathyroid hormone-related protein (PTHrP) in transgenic mice overexpressing the PTH/PTHrP receptor in vascular smooth muscle. Endocrinology 140 (1999) 1826-1833
10. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
11. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
12. Singer F.R. Parathyroid hormone-related protein. Mayo Clin Proc 65 (1990) 1502-1505
13. Takahashi K., Inoue D., Ando K., Matsumoto T., Ikeda K., and Fujita T. Parathyroid hormone-related peptide as a locally produced vasorelaxant: regulation of its mRNA by hypertension in rats. Biochem Biophys Res Commun 208 (1995) 447-455
14. Zhang D., Gaussin V., Taffet G.E., Belaguli N.S., Yamada M., Schwartz R.J., et al. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat Med 6 (2000) 556-563